GlassScriptPhysician profile
Joseph Caresio
NPI 1043266117
$5,134.78
in general payments reported to CMS, 2019-2025
13 companies · $969 in 2025
The $969 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,532 · 2020: $128 · 2021: $229 · 2022: $1,663 · 2023: $73.41 · 2024: $539 · 2025: $969.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $824 · Food and Beverage: $757.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $823.98 |
| Food and Beverage | $757.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $2,078.44 | 2020-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Vertiflex, INC. | $1,270.42 | 2019 | |
| Angiodynamics, INC. | $1,206.21 | 2023-2025 | Alphavac |
| Stryker Corporation | $141.39 | 2019-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Nevro Corp. | $136.69 | 2019 | |
| Cook Medical LLC | $64.47 | 2020-2022 | |
| Baudax Bio INC. | $62.64 | 2020-2022 | |
| Sanofi Pasteur INC. | $46.14 | 2022 | |
| Sanofi-Aventis U.S. LLC | $39.48 | 2019 | |
| Immunitybio, INC. | $29.92 | 2025 | |
| Penumbra, INC. | $22.76 | 2024 | Indigo System |
| Argon Medical Devices, INC. | $20.99 | 2019 | |
| W. L. Gore & Associates, INC. | $15.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Caresio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.